• Z-LEHD-FMK: Irreversible Caspase-9 Inhibitor for Apoptosis A

  2026-05-20

  Z-LEHD-FMK empowers researchers to dissect mitochondria-mediated apoptosis and its interplay with pyroptosis, offering selective, irreversible inhibition of caspase-9. This enables high-precision apoptosis assays and neuroprotection studies, as well as innovative troubleshooting for complex cell death models.

• Angiotensin (1-7): Protocols and Applied Insights for Transl

  2026-05-20

  Angiotensin (1-7) empowers researchers with precise, reproducible modulation of anti-fibrotic, anti-inflammatory, and metabolic pathways. This article delivers stepwise protocols, troubleshooting guidance, and new cross-domain insight—anchored by recent evidence—for leveraging APExBIO’s high-purity peptide in advanced experimental designs.

• DMG-PEG2000-NH2: Transforming Lipid Nanoparticle Drug Delive

  2026-05-19

  Explore how DMG-PEG2000-NH2 is redefining the mechanistic and translational landscape of liposomal and lipid nanoparticle platforms, with new insights into its role as a bioconjugation and delivery enabler. This article bridges recent advances in PEGylation chemistry with practical protocol guidance for antimicrobial and nucleic acid therapeutics, uniquely contextualizing APExBIO’s DMG-PEG2000-NH2 within the evolving drug delivery ecosystem.

• Anti-Inflammatory, Anti-Angiogenic Stent Suppresses TISR

  2026-05-19

  Zhao et al. introduce an airway stent engineered with both anti-inflammatory and anti-angiogenic properties, significantly reducing tracheal in-stent restenosis (TISR) in a rabbit model. This work demonstrates that dual-modality stent design can curb excessive vascularization and fibroblast activation, offering a promising strategy to enhance airway stent efficacy and durability.

• PR-619: Technical Guidance for DUB Inhibition Workflows

  2026-05-18

  PR-619 is a reversible, broad-spectrum deubiquitylating enzymes inhibitor designed for precise interrogation of ubiquitination pathways. It is best suited for cell-based assays in cancer and neurodegenerative disease models but requires careful handling due to solubility constraints and cytotoxicity at low micromolar concentrations. Use is not recommended where direct proteasomal inhibition or long-term solution storage is necessary.

• BRD4 Inhibition Modulates AKT-SIRT3 Axis in Hyperoxia Lung I

  2026-05-18

  This study uncovers a mechanistic link between BRD4 inhibition and activation of the AKT-SIRT3 signaling pathway, revealing a protective effect against hyperoxia-induced lung injury in alveolar epithelial cells. The findings highlight BRD4 as a promising therapeutic target for mitigating apoptosis and oxidative stress in pulmonary injury models.

• TCF25 Regulates Lysosomal Acidification Under Glucose Starva

  2026-05-17

  Ren et al. (2025) identify TCF25 as a nutrient sensor that regulates metabolic adaptation and cell death by promoting lysosomal acidification and ferritinophagy during glucose starvation. This work reveals new mechanistic insight into how cells balance survival and death under energy stress, with implications for metabolic and ischemic diseases.

• Technical Use of HyperScribe™ T7 High Yield Cy3 RNA Labeling

  2026-05-16

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus addresses the challenge of generating high-yield, fluorescently labeled RNA probes for sensitive detection in in situ hybridization and Northern blot workflows. This kit is strictly for research use and is not suitable for diagnostic or clinical applications.

• Hexa His Tag Peptide: Optimizing 6X His Tag Protein Purifica

  2026-05-15

  The Hexa His tag peptide empowers highly specific and contamination-free purification of His-tagged proteins, streamlining workflows for both classic and advanced protein interaction studies. This guide distills protocol enhancements, troubleshooting, and the latest insights from actin assembly research—bridging mechanistic detail with practical, reproducible assay design.

• Caffeine as a Translational Tool: Mechanisms, Models, and Be

  2026-05-15

  This thought-leadership article, authored by APExBIO’s head of scientific marketing, provides a mechanistic and strategic roadmap for translational researchers leveraging caffeine (1,3,7-trimethylpurine-2,6-dione) in cancer, metabolic, and obesity research. Integrating recent experimental findings, rigorous protocol guidance, and comparative landscape insight, it demonstrates how caffeine’s bioactivity and well-characterized handling profile empower reproducible, high-impact bench-to-bedside work.

• Fluorescein TSA Fluorescence System Kit: Amplifying Sensitiv

  2026-05-14

  The Fluorescein TSA Fluorescence System Kit unlocks ultrasensitive detection of low-abundance biomolecules, empowering robust immunohistochemistry, immunocytochemistry, and in situ hybridization workflows. Its tyramide signal amplification mechanism ensures high signal-to-noise and precise spatial mapping, even in challenging tissue samples.

• Systemic Impacts of Epinephrine in Dental Local Anesthesia

  2026-05-14

  This review examines the systemic effects and optimal concentrations of epinephrine as a vasoconstrictor in dental local anesthetic solutions. Key findings clarify how different concentrations affect anesthetic duration, hemostasis, and the risk of adverse cardiovascular events, guiding safer and more effective anesthesia protocols.

• Gentamycin Sulfate: Mechanisms and Research-Grade Applicatio

  2026-05-13

  Gentamycin Sulfate is a potent aminoglycoside antibiotic widely used in bacterial protein synthesis research and the study of antibiotic resistance mechanisms. Its mechanism involves precise inhibition of the bacterial 30S ribosomal subunit, making it a benchmark tool for Gram-negative infection models in laboratory settings.

• Tropifexor (LJN452): Potent FXR Agonist for Barrier Function

  2026-05-13

  Tropifexor (LJN452) is a highly potent Farnesoid X Receptor (FXR) agonist with an EC50 of ~0.2 nM. It robustly enhances intestinal epithelial barrier integrity and defense responses in preclinical models, making it a valuable tool for metabolic and intestinal disease research.

• Sulfo-Cy3 NHS Ester: Hydrophilic Fluorescent Dye in High-Fid

  2026-05-12

  Explore the advanced use of Sulfo-Cy3 NHS Ester, a hydrophilic fluorescent dye, for precise protein conjugation and low-background labeling in challenging biochemical contexts. This article uniquely connects technical assay optimization to insights from vascular remodeling research.

16492 records 1/1100 page Next 12345 下5页 Last page